• Home
  • Changchun BCHT Biotechnology Co.
8-10
Jul
2026
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
M37
Book a meeting
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
12F53
Book a meeting

Changchun BCHT Biotechnology Co.

About Changchun BCHT Biotechnology Co.

Changchun BCHT Biotechnology Co. is an innovative biopharmaceutical enterprise dedicated to the prevention and treatment of infectious diseases. Since its establishment in 2004, specializing in the R&D, production and sales of human vaccines. At present, BCHT has its own vaccine manufacturing base, covering 225,700㎡ in total, on the basis of core technology R&D and industrialization, BCHT has built stable business model and high market recognition. The company initially offered to the public and successfully listed on the Science and Technology Innovation Board in 2021.

Read more Show less
Categories
more categories Show less

Meet us at

  • CPHI South East Asia 2026

    CPHI South East Asia 2026

    QSNCC, Bangkok, Thailand
    08 Jul 2026 - 10 Jul 2026
  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2023
Contact info
  • +86 431 87078891
  • 138 Zhuoyue Street, Changchun High-tech Zone,, 130103, Jilin, China
Show contact info Hide contact info

Products from Changchun BCHT Biotechnology Co. (3)

  • Herpes Zoster Vaccine, Live

    Product Herpes Zoster Vaccine, Live

    The Herpes Zoster Vaccine, Live produced by BCHT was approved for marketing in January 2023 which is the world's first Herpes Zoster Vaccine, Live for people aged at or above 40 years old, it fills the gap in domestic herpes zoster vaccines market.

  • Influenza Vaccine, Live, Nasal, Freeze-dried

    Product Influenza Vaccine, Live, Nasal, Freeze-dried

    Influenza Vaccine, Live, Nasal, Freeze-dried (launched in 2020), a novel influenza attenuated live vaccine, is a cooperative project with the WHO, which has been included in Global Action Plan for Influenza Vaccine(GAP), it fills the gap in domestic influenza attenuated live vaccines market and has broad m...
  • Varicella Vaccine, Live

    Product Varicella Vaccine, Live

    In 2008, BCHT successfully launched Varicella Vaccine, Live which owned independent intellectual property, its shelf-life up to 36 months which is the longest one in the world, the market share rank first for many years in China. 

Changchun BCHT Biotechnology Co. Resources (1)